Combination of Nimotuzumab and Radiotherapy for Recurrent and Metastatic Uterine Cervical Squamous Carcinoma: a Single-arm, Open, Phase 2 Clinical Trial
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Cervical cancer; Squamous cell cancer; Uterine cancer
- Focus Therapeutic Use
- 18 Dec 2020 Status changed from not yet recruiting to recruiting.
- 16 Dec 2020 New trial record